International Pharmaceutical Regulatory Monitor
November 2012
| Vol.
40 No.
11
Safety Risks Seen in Health Canada Priority Approvals Could Signal System Flaws
A new study finds one-third of drugs approved using Health Canada’s priority approval process eventually develop safety problems.
This article is viewable by subscribers only. To view this article, please select an option below.
|